CD, cluster of differentiation; FACS, fluorescence-activated cell sorter; Flk-1, vascular endothelial growth factor receptor 1; Stro-1, stromal ... Recruiting Mesenchymal Stem Cells in Multiple ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC ... According to its proposed mechanism of action, remestemcel-L reduces systemic inflammation by way of ...

A translational research program focused on developing next-generation cell therapies by characterizing the elusive identity and function of mesenchymal stem and stromal cells (MSC) in physiological ...

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

The study found that the mesenchymal-like properties of these cells are associated with an enhanced ability to modulate their ...

CORDStrom is a patent-pending cell medicine comprising aseptic, allogeneic, pooled human umbilical cord-derived mesenchymal stromal cells (hucMSCs) in suspension for injection or infusion. The ...

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...